睿创微纳(688002) - 2021 Q1 - 季度财报

Financial Performance - Operating income rose by 64.94% to CNY 380,597,510.22 year-on-year, driven by strong sales of infrared detectors and thermal imaging products [5]. - Net profit attributable to shareholders increased by 42.04% to CNY 120,781,379.74 compared to the same period last year [3]. - Basic earnings per share increased by 42.02% to CNY 0.2714 compared to the same period last year [3]. - Total revenue for Q1 2021 reached ¥380,597,510.22, a 64.94% increase compared to ¥230,744,131.53 in Q1 2020 [12]. - Gross profit margin improved significantly, with cost of sales at ¥152,364,628.24, reflecting a 60.72% increase from the previous year [12]. Cash Flow and Investments - Cash flow from operating activities surged by 196.09% to CNY 60,999,162.07 year-on-year [3]. - Net cash flow from operating activities rose by 196.09% to ¥60,999,162.07, primarily due to increased cash receipts from sales of goods and services [13]. - Investment activities generated a net cash flow of -¥428,309,262.34, a 460.43% increase compared to the previous year, mainly due to higher investments in financial products and long-term productive assets [13]. - Financing activities resulted in a net cash flow of -¥2,187,198.84, a decrease of 104.38% as the company repaid short-term loans and absorbed minority shareholder investments [13]. - Investment income increased by 97.68% to ¥2,285,843.46, attributed to profits from investments in joint ventures [13]. Revenue Breakdown - Revenue from civilian products reached CNY 30,990,100, accounting for 82.30% of total operating income, up 77.83% year-on-year [5]. - Domestic revenue grew by 31.60% to CNY 22,810,800, while overseas revenue skyrocketed by 167.11% to CNY 14,842,290 [5]. Shareholder Information - The company had a total of 11,040 shareholders at the end of the reporting period [8]. - The number of shareholders at the end of the reporting period was not specified, but the top ten shareholders held significant stakes, with the largest being 18,500,000 shares, representing 4.16% [9]. Expenses and Costs - Research and development expenses accounted for 16.65% of operating income, an increase of 4.06 percentage points from the previous year [5]. - The company’s sales expenses surged by 194.76% to ¥13,823,299.06, reflecting increased sales efforts [12]. - Management expenses increased by 44.55% to ¥14,229,667.34 due to rising labor costs [13]. - R&D expenses surged by 118.23% to ¥63,373,155.41 as the company continued to increase its investment in research and development [13]. Asset and Liability Changes - Total assets increased by 4.60% to CNY 3,707,574,323.56 compared to the end of the previous year [3]. - Accounts receivable increased by 14.80% to ¥370,165,850.56, attributed to higher sales during the reporting period [11]. - Inventory rose by 15.77% to ¥825,701,243.85, driven by increased production and sales volume [11]. - The company reported a 927.58% increase in trading financial assets, totaling ¥370,349,232.88, due to investments in structured deposit products [11]. - Short-term borrowings decreased by 100% to zero, as the company repaid bank credit loans during the reporting period [12]. Tax and Impairment - The company reported a 34.14% increase in income tax expenses to ¥15,604,441.38, driven by an increase in total profit [13]. - Credit impairment losses decreased by 15.58% to -¥4,622,952.38, as accounts receivable increased less than in the same period last year [13]. - Asset impairment losses increased significantly by 4,439.06% to -¥4,724,037.64, primarily due to increased provisions for inventory write-downs [13]. Future Outlook - The company plans to continue expanding its market presence and product offerings, although specific future strategies were not detailed in the provided content [10].